arrow
P

Péter Ferenci

Medical University of Vienna
H指数:75
被引数:2.9万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Eligibility for antiviral therapy and treatment uptake in chronic hepatitis B patients referred to a European tertiary care center

被转介到欧洲三级护理中心的慢性乙型肝炎患者的抗病毒治疗和治疗摄取的资格

2023-03-253
OAAI
Alpha-1 antitrypsin Pi*Z allele is an independent risk factor for liver transplantation and death in patients with advanced chronic liver disease
2022-11-018
OAAI
Ethyl glucuronide in hair detects a high rate of harmful alcohol consumption in presumed non-alcoholic fatty liver disease

头发中的乙基葡萄糖醛酸苷在假定的非酒精性脂肪肝疾病中检测到有害的酒精消耗率高

2022-10-0193
OA
Response-guided long-term treatment of chronic hepatitis D patients with bulevirtide-Results of A real world Study
2022-05-0538
OAAI
HCC risk stratification after cure of hepatitis C in patients with compensated advanced chronic liver disease

代偿性晚期慢性肝病患者治愈丙型肝炎后的HCC风险分层

2022-04-0185
OA
Synonymous mutation in adenosine triphosphatase copper-transporting beta causes enhanced exon skipping in Wilson disease
2022-03-108
OAAI
Safety and effectiveness of up to 3 years' bulevirtide monotherapy in patients with HDV-related cirrhosis

在HDV相关肝硬化患者中长达3年的布列维肽单药治疗的安全性和有效性

2022-02-0151
PRE
Hepatitis D virus (HDV) prevalence in Austria is low but causes considerable morbidity due to fast progression to cirrhosis

奥地利的丁型肝炎病毒 (HDV) 患病率较低,但由于快速进展为肝硬化而导致相当高的发病率

2021-12-0724
OAAI
Designing Clinical Trials in Wilson's Disease

设计威尔逊氏病的临床试验

2021-12-0112
OAAI